Mechanisms that affect reimbursement prices for medical devices in Japan, the world’s third largest medical device market: A scoping review

报销 医学 经皮冠状动脉介入治疗 传统PCI 医疗保健 财务 业务 心脏病学 经济 经济增长 心肌梗塞
作者
Satoru Hashimoto,Yoshihiro Motozawa,Takamitsu Mano
出处
期刊:International journal of healthcare management [Taylor & Francis]
卷期号:: 1-8 被引量:2
标识
DOI:10.1080/20479700.2023.2250612
摘要

ABSTRACTBackground Over the past two decades, Japanese reimbursement prices for medical devices used for percutaneous coronary intervention (PCI) were greatly reduced. This scoping review aimed to identify the mechanisms that influence the reimbursement prices of medical devices in Japan, such as devices used in cardiovascular diseases.Methods PubMed and Google Scholar were searched from their inception through July 31, 2022, for possible mechanisms that affect reimbursement in Japan.Results Reimbursement prices for PCI-related medical devices have declined since the middle of the 1990s because of the increasing number of PCI procedures performed due to an ageing society, differences in domestic and international prices, and differences between reimbursement prices and prevailing prices. In addition, the reimbursement price of medical devices is affected by the Health Technology Assessment, which considers the cost-effectiveness of medical devices and the market expansion re-pricing system, which is imposed on medical devices whose market has expanded significantly beyond the projections at the time of insurance listing.Conclusion Reimbursement prices of medical devices in Japan were primarily affected by three mechanisms aimed at controlling the healthcare expenditure; however, recently, in addition to these, the reimbursement price is evaluated from an economic perspective, including cost-effectiveness and market projection.Abbreviations: DES, Drug-eluting stent; EVAR, endovascular aneurysm repair; HTA, Health Technology Assessment; JFTC, Japanese Fair-Trade Commission; JROAD, Japanese registry of all cardiac and vascular disease; MHLW: Ministry of Health, Labor, and Welfare; NHRS, national health reimbursement system; PCI, percutaneous coronary intervention; TAVI, transcatheter aortic valve implantation; TEVAR, thoracic endovascular aortic repairKEYWORDS: Reimbursementprice mechanismpercutaneous coronary interventionPCI-related medical deviceshealth technology assessment AcknowledgementsThe authors would like to thank Ms. Keiko Takahashi for her help in the preparation of the figures and tables, Ms. Rie Arai for her research assistance and Mr. Emmanuel Asika for the English language editing.Data availability statementAvailable upon the request.Disclosure statementNo potential conflict of interest was reported by the author(s).Contributors: Satoru Hashimoto made a concept, research, and design of the article. Dr. Yoshihiro Motozawa provided his clinical experience, interpret the data, and supported writing the article. Professor Toshiki Mano was responsible for final approval of the article to be submitted.Additional informationNotes on contributorsSatoru HashimotoSatoru Hashimoto BS, MBA after a consistent career in sales and marketing in the cardiovascular intervention field, founded TCROSS Co., Ltd, in 2005. He received his MBA from the Graduate School of Management, Globis University, in 2021. Hashimoto is currently studying medical innovation in a doctoral program at Chuo University.Yoshihiro MotozawaYoshihiro Motozawa MD, PhD after graduating from the University of Tokyo, School of Medicine, he began his clinical career as a cardiologist. He then went on to obtain his Ph.D. in Medicine from the University of Tokyo. He currently works at hospital as a clinician while working as a business consultant in TCROSS Co., Ltd.Toshiki ManoToshiki Mano MD, PhD After gaining clinical experience as a diabetes physician, Prof. Mano studied at Cornell University Medical School as a research fellow. He later earned an MBA from the University of Leicester Graduate School of Medicine in the UK while working in the management for a pharmaceutical company. Prof. Mano also holds a PhD in economics from Kyoto University. He is currently involved in the MBA education programs and serves as Chairman of the Hospital Committee of the Ministry of Health, Labor and Welfare, and the Japan Medical Association.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
机灵的芷珊完成签到,获得积分10
刚刚
锦鲤发布了新的文献求助200
刚刚
所所应助超帅的成败采纳,获得10
刚刚
脑洞疼应助冯冯采纳,获得10
刚刚
王永明发布了新的文献求助10
刚刚
Hexagram完成签到 ,获得积分10
刚刚
赘婿应助Seth采纳,获得10
1秒前
sss发布了新的文献求助30
1秒前
WRT完成签到,获得积分20
1秒前
火乐完成签到 ,获得积分10
1秒前
1秒前
NATIESNAFTANG发布了新的文献求助10
1秒前
2秒前
白白完成签到,获得积分20
2秒前
风趣静枫完成签到,获得积分20
2秒前
2秒前
molihuakai应助易北采纳,获得10
2秒前
xueyu发布了新的文献求助10
2秒前
ddl发布了新的文献求助10
3秒前
多多完成签到,获得积分10
3秒前
Mcintosh完成签到,获得积分10
3秒前
迷路白薇发布了新的文献求助10
3秒前
科目三应助金阿林在科研采纳,获得10
3秒前
3秒前
3秒前
wangyue发布了新的文献求助10
3秒前
豆奶发布了新的文献求助10
4秒前
psybrain9527完成签到,获得积分10
4秒前
4秒前
的地方法规完成签到,获得积分10
4秒前
4秒前
yiyi完成签到 ,获得积分10
5秒前
5秒前
WRT发布了新的文献求助10
5秒前
CipherSage应助程尘采纳,获得10
5秒前
inspirx发布了新的文献求助10
5秒前
伤心大蟑螂应助tk采纳,获得20
5秒前
6秒前
在水一方应助yyer采纳,获得10
6秒前
6秒前
高分求助中
Overcoming Stigma and Bias in Obesity Management 800
Malcolm Fraser : a biography 700
Signals, Systems, and Signal Processing 610
Bounds for Statistical Estimation in Semiparametric Models 500
Climate change and sports: Statistics report on climate change and sports 500
Forced degradation and stability indicating LC method for Letrozole: A stress testing guide 500
Ideology and Meaning-Making under the Putin Regime 450
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6475100
求助须知:如何正确求助?哪些是违规求助? 8277917
关于积分的说明 17652213
捐赠科研通 5555943
什么是DOI,文献DOI怎么找? 2910182
邀请新用户注册赠送积分活动 1887026
关于科研通互助平台的介绍 1739694